Canopy Growth (CGC) Competitors $1.08 -0.02 (-1.82%) Closing price 08/5/2025 04:00 PM EasternExtended Trading$1.08 +0.00 (+0.46%) As of 08/5/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CGC vs. ACB, CRON, OGI, SNDL, TLRY, VFF, STZ, LENZ, MLYS, and SIONShould you be buying Canopy Growth stock or one of its competitors? The main competitors of Canopy Growth include Aurora Cannabis (ACB), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), Tilray Brands (TLRY), Village Farms International (VFF), Constellation Brands (STZ), LENZ Therapeutics (LENZ), Mineralys Therapeutics (MLYS), and Sionna Therapeutics (SION). Canopy Growth vs. Its Competitors Aurora Cannabis Cronos Group Organigram Global SNDL Tilray Brands Village Farms International Constellation Brands LENZ Therapeutics Mineralys Therapeutics Sionna Therapeutics Canopy Growth (NASDAQ:CGC) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment and earnings. Do institutionals and insiders have more ownership in CGC or ACB? 3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 1.3% of Canopy Growth shares are held by insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is CGC or ACB more profitable? Aurora Cannabis has a net margin of 1.32% compared to Canopy Growth's net margin of -195.76%. Aurora Cannabis' return on equity of 0.13% beat Canopy Growth's return on equity.Company Net Margins Return on Equity Return on Assets Canopy Growth-195.76% -88.54% -40.78% Aurora Cannabis 1.32%0.13%0.10% Which has preferable valuation and earnings, CGC or ACB? Aurora Cannabis has higher revenue and earnings than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCanopy Growth$225.65M0.98-$429.86M-$4.04-0.27Aurora Cannabis$246.72M1.05$1.63M$0.1141.82 Which has more volatility & risk, CGC or ACB? Canopy Growth has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.84, suggesting that its share price is 84% more volatile than the S&P 500. Does the media favor CGC or ACB? In the previous week, Canopy Growth had 3 more articles in the media than Aurora Cannabis. MarketBeat recorded 5 mentions for Canopy Growth and 2 mentions for Aurora Cannabis. Canopy Growth's average media sentiment score of 0.53 beat Aurora Cannabis' score of 0.25 indicating that Canopy Growth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Canopy Growth 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer CGC or ACB? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67 SummaryAurora Cannabis beats Canopy Growth on 13 of the 16 factors compared between the two stocks. Get Canopy Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CGC vs. The Competition Export to ExcelMetricCanopy GrowthMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$225.66M$10.59B$5.59B$9.53BDividend YieldN/A2.00%4.73%4.14%P/E Ratio-0.2719.2928.9223.88Price / Sales0.9827.93445.6298.82Price / CashN/A22.1035.6858.35Price / Book0.573.888.165.60Net Income-$429.86M$211.77M$3.25B$265.26M7 Day Performance2.86%1.29%1.18%-0.14%1 Month Performance-16.60%4.55%8.27%6.08%1 Year Performance-83.15%-10.58%29.20%24.22% Canopy Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CGCCanopy Growth0.45 of 5 stars$1.08-1.8%N/A-82.2%$225.66M$225.65M-0.273,150Upcoming EarningsACBAurora Cannabis0.6156 of 5 stars$4.78-1.2%N/A-17.0%$268.86M$343.29M43.451,130CRONCronos Group2.3994 of 5 stars$2.06+0.5%N/A-5.9%$794.50M$117.61M15.85450Upcoming EarningsOGIOrganigram Global1.253 of 5 stars$1.48-3.3%N/A-3.5%$198.23M$117.47M14.80860Upcoming EarningsSNDLSNDL2.8024 of 5 stars$1.50-1.0%$4.00+166.7%-20.2%$394.17M$671.81M-5.172,516Earnings ReportAnalyst RevisionTLRYTilray Brands3.1079 of 5 stars$0.70+1.6%$1.92+173.9%-63.2%$704.25M$210.48M-0.672,650Options VolumeAnalyst RevisionVFFVillage Farms International2.6536 of 5 stars$1.47-3.3%N/A+74.0%$165.14M$335.18M-4.081,400Upcoming EarningsSTZConstellation Brands4.6352 of 5 stars$172.70-1.6%$213.74+23.8%-27.8%$30.45B$10.96B-72.2610,600Positive NewsLENZLENZ Therapeutics1.6859 of 5 stars$31.51-0.3%$48.60+54.2%+36.8%$887.01MN/A-17.80110Earnings ReportUpcoming EarningsAnalyst RevisionGap UpMLYSMineralys Therapeutics2.5585 of 5 stars$13.60-5.0%$32.25+137.1%+20.2%$886.38MN/A-3.6528Upcoming EarningsSIONSionna TherapeuticsN/A$19.85+3.9%$38.50+94.0%N/A$875.86MN/A0.0035Lockup Expiration Related Companies and Tools Related Companies ACB Competitors CRON Competitors OGI Competitors SNDL Competitors TLRY Competitors VFF Competitors STZ Competitors LENZ Competitors MLYS Competitors SION Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CGC) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Canopy Growth Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Canopy Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CGC Stock Alerts